Key facts
- This page summarizes Michael Jay Lane's Form 4 filing for MedMen Enterprises, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Oct 2021, 19:25.
Michael Jay Lane - 29 Aug 2021 Form 4 Insider Report for MedMen Enterprises, Inc.
- SEC form
- 4
- Accepted by SEC
- 05 Oct 2021, 19:25:06 UTC
- Prior SEC filing
- 05 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Jay Lane
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Jay Lane filed Form 4 for MedMen Enterprises, Inc. on 05 Oct 2021.
Change
- Previous filing in this sequence was filed on 05 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MMNFF
transaction
Class B Subordinate Voting Shares
Award
- Transaction value
- $0
- Shares
- +781,809
- Change %
- +57%
- Price
- $0.000000
- Shares after
- 2,154,816
- Date
- 29 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MMNFF
transaction
Derivative
Employee Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +196,851
- Change %
- Price
- $0.000000
- Shares after
- 196,851
- Date
- 29 Aug 2021
- Ownership
- Direct
- Underlying class
- Class B Subordinate Voting Shares
- Underlying amount
- 196,851
- Exercise price
- $0.2814
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Issued pursuant to Issuer's 2018 Stock Incentive Plan.
Footnote F2
Represents restricted stock units ("RSUs"), which vest annually over four years beginning 6/30/2022, with 37.5% of shares vesting on 6/30/2022 and 6/30/2024, and 12.5% of shares vesting on 6/30/2023 and 6/30/2025. RSUs are equivalent to Issuer's Class B Subordinate Voting Shares and may be settled solely by delivery of an equal number of such shares of Issuer.
Footnote F3
Such options have an exercise price of CAN$0.355, which is US$0.2814 at an exchange rate of 1.2635.